Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Executives to Speak at Upcoming Investor Conferences

09/07/2021 | 11:01am EDT

DUBLIN, Sept. 7, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences:

2021 Virtual Wells Fargo Healthcare Conference
Thursday, September 9, 2021, at 10:40 am EDT
Bob White, executive vice president & president, Medical Surgical Portfolio, will answer questions about the company.

Morgan Stanley 19th Annual Global Healthcare Conference
Tuesday, September 14, 2021, at 10:15 am EDT
Geoff Martha, Medtronic chairman & chief executive officer, will answer questions about the company.

BofA Global Healthcare Conference 2021
Friday, September 17, 2021 at 12:35 pm EDT
Rob ten Hoedt, executive vice president & president, EMEA, will answer questions about the company.

A live webcast for each session will be available on the date and time of each of the conferences noted above by clicking on the Investors Events link at http://investorrelations.medtronic.com. An archived audio file will be available for replay on the same webpage later in the day.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. 

Contacts:




Erika Winkels          

Ryan Weispfenning

Public Relations       

Investor Relations

+1-763-526-8478     

+1-763-505-4626

Medtronic plc (PRNewsfoto/Medtronic plc)

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-executives-to-speak-at-upcoming-investor-conferences-301369937.html

SOURCE Medtronic plc

© Canada Newswire, source Canada Newswire English

All news about MEDTRONIC PLC
10/19MEDTRONIC : Children achieve Time in Range mirroring well-controlled adults for the first ..
PR
10/18MEDTRONIC : Shares Down Midday After DSMB Recommends Continued Enrollment of Symplicity Tr..
MT
10/18MEDTRONIC : Wells Fargo Adjusts Price Taget on Medtronic to $144 from $151, Keeps Overweig..
MT
10/18Medtronic Plc Down Over 5%, On Pace for Largest Percent Decrease Since June 2020 -- Dat..
DJ
10/17Medtronic Reportedly in Talks to Buy Insulin Pump Patch Maker Triple Jump
CI
10/15MEDTRONIC PLC : Regulation FD Disclosure (form 8-K)
AQ
10/13OPSENS : Says "Successfully Treats" First Patients in Human Clinical Study for TAVR Proced..
MT
10/12MEDTRONIC : Sets New ESG Targets
MT
10/12MEDTRONIC : announces new ESG targets in its FY21 Integrated Performance Report and unveil..
PR
10/12MEDTRONIC : Hugo Robotic-Assisted Surgery System Receives European CE Mark Approval
AQ
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 990 M - -
Net income 2022 5 614 M - -
Net Debt 2022 20 291 M - -
P/E ratio 2022 30,9x
Yield 2022 1,96%
Capitalization 164 B 164 B -
EV / Sales 2022 5,60x
EV / Sales 2023 5,26x
Nbr of Employees 90 000
Free-Float 99,7%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Last Close Price 122,20 $
Average target price 145,52 $
Spread / Average Target 19,1%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC4.32%164 458
ABBOTT LABORATORIES9.00%211 568
BECTON, DICKINSON AND COMPANY-2.99%69 710
HOYA CORPORATION23.83%57 064
DEXCOM, INC.48.77%53 217
SARTORIUS STEDIM BIOTECH61.85%50 552